Status:

UNKNOWN

Blood Glucose Stability and Variability on Two Diets

Lead Sponsor:

Nutrisystem, Inc.

Collaborating Sponsors:

University of Pennsylvania

Conditions:

Type 2 Diabetes

Obesity

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

This investigation will examine the effects of consuming a structured, portion-controlled, low-glycemic index diet (commercially available as the Nutrisystem-D program) on several indicators of glycem...

Detailed Description

This study will investigate glycemic stability and variability in response to two diets: usual diet and a commercially available portion-controlled diet. The commercially available diet will be the Nu...

Eligibility Criteria

Inclusion

  • Diagnosis of type 2 diabetes
  • Body mass index (BMI) of 27 to 45 kg/m2
  • Capacity to provide written informed consent
  • Willing and committed to return for all clinic visits and complete all study-related procedures
  • Men and women of all racial and ethnic groups are eligible for participation

Exclusion

  • Use of hypoglycemic medications (e.g., sulfonylureas, insulin)
  • Food allergies or intolerances that would render adherence to the test diets unpleasant or unsafe
  • Use of anticoagulant medications (e.g., warfarin)
  • Pregnant or lactating
  • More than a 5% weight gain or loss within the last 3 months
  • More than one alcoholic drink per day
  • Binge eating disorder
  • Regular use of acetaminophen

Key Trial Info

Start Date :

December 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2011

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT01443143

Start Date

December 1 2010

End Date

December 1 2011

Last Update

September 29 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pennsylvania Center for Weight and Eating Disorders

Philadelphia, Pennsylvania, United States, 190104